Interested in how others track chemotherapy lifetime doses.

Does your pharmacy track cumulative doses for patients? If no, who is responsible for tracking? Is tracking a manual process for you or is this automated through your EHR? How do you accurately monitor cumulative doses when all doses are not given at a single facility?

I appreciate any insight that you can share!

Hello All,

I am wondering if anyone knows of any articles, MSOS or ISMP recommendations that explicitly state what should be included in IV Administration Guidelines (i.e. monitoring parameters, dilution for push meds, 'special circumstances').
All input would be appreciated.

Karen Haynes PharmD
Clinical Lead Pharmacist
Winchester Hospital
karensue.haynes@lahey.org

Does anyone have a formal policy or procedure for appropriate actions to take when a TPN becomes disconnected? Our formal stance is to not disconnect the line at all if possible. If something happens to interrupt the line we typically advise not to re-connect a TPN due to infectious risk but I haven't been able to find any great resources to back up this recommendation.

can we keep waste bin made of plastic inside the Verical Laminar Flow Hood to put extra fluid inside the waste bin to diminish hand movement outside of VLFH

Below are the links to two of the items discussed during today's MSOS Briefing webinar:

The Medication Safety Minute flipbook: http://online.fliphtml5.com/hktg/ivgg/

The International Medication Safety Network: https://www.intmedsafe.net/

APNO is a recommended therapy by various breastfeeding organizations for breastfeeding moms to apply to the nipples after feedings. The ingredients are miconazole, betamethasone, and mupirocin.

I was unable to find safety data for possible exposure of the neonate/infant. My biggest concern is for oral absorption of topical betamethasone by the baby.

Our hospital has been compounding this for use in our patients, but I have some concerns given there isn't any true evidence of efficacy or safety.

I would appreciate any help or insight on this. Thank you.

Dear colleagues,
I would like to know the process for adding a new medication on the formulary. Especially when a decision is required to select 01 brand among multiple brands available for a generic. whats the criteria for selection? who is the decision maker; the pharmacy or a Purchase dept.?

If you could share your formulary addition policy that would be of great help.

thanks,
Saharish

Can you describe your dispensing practices for intralipids when the total Bag volume far exceeds the daily volume prescribed? Do you transfer to patient specific syringes? If so what is the allowed hang time? If you dispense bags what safety mechanisms do you have in place to prevent overdoses?

Which software or application your site use for reporting and analyzing ADRs and ADEs? Our system currently use the one from Datix but it is controlled by Risk and was not designed with specific ADR reporting and analzying capabilities (e.g. no probability scale). We are considering either EPIC or REDCap. Any input or insight is greatly appreciated!

Good afternoon, I'm wondering if anyone is willing to share how you organize your Med Safety Committee agenda? How do you determine what topics make it to the agenda? And if you work for a system, do all the facilities use the same agenda?

There's been lots posted about metrics, but I'm more interested in an agenda template.

For instance, here's a few things on ours: old business/follow-up, dashboard, preventable ADR reports, update from the system committee.

Thanks,
Joanie